Detalhe da pesquisa
1.
Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition.
Immunity
; 55(11): 2135-2148.e6, 2022 11 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36306784
2.
A potently neutralizing SARS-CoV-2 antibody inhibits variants of concern by utilizing unique binding residues in a highly conserved epitope.
Immunity
; 54(10): 2399-2416.e6, 2021 10 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34481543
3.
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates.
N Engl J Med
; 383(16): 1544-1555, 2020 10 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32722908
4.
Improved delivery of broadly neutralizing antibodies by nanocapsules suppresses SHIV infection in the CNS of infant rhesus macaques.
PLoS Pathog
; 17(7): e1009738, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-34283885
5.
TLR7 agonist, N6-LS and PGT121 delayed viral rebound in SHIV-infected macaques after antiretroviral therapy interruption.
PLoS Pathog
; 17(2): e1009339, 2021 02.
Artigo
Inglês
| MEDLINE | ID: mdl-33600506
6.
Anatomic Distribution of Intravenously Injected IgG Takes Approximately 1 Week to Achieve Stratum Corneum Saturation in Vaginal Tissues.
J Immunol
; 207(2): 505-511, 2021 07 15.
Artigo
Inglês
| MEDLINE | ID: mdl-34162723
7.
Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody.
Proc Natl Acad Sci U S A
; 117(31): 18754-18763, 2020 08 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32690707
8.
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges.
Nature
; 533(7601): 105-109, 2016 May 05.
Artigo
Inglês
| MEDLINE | ID: mdl-27120156
9.
Delayed vaginal SHIV infection in VRC01 and anti-α4ß7 treated rhesus macaques.
PLoS Pathog
; 15(5): e1007776, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-31083697
10.
Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopes.
PLoS Pathog
; 15(4): e1007632, 2019 04.
Artigo
Inglês
| MEDLINE | ID: mdl-30943274
11.
Use of broadly neutralizing antibodies for HIV-1 prevention.
Immunol Rev
; 275(1): 296-312, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-28133803
12.
Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation.
PLoS Pathog
; 14(5): e1007024, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29718999
13.
Bispecific antibodies: Potential immunotherapies for HIV treatment.
Methods
; 154: 118-124, 2019 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30352254
14.
Enhanced neonatal Fc receptor function improves protection against primate SHIV infection.
Nature
; 514(7524): 642-5, 2014 Oct 30.
Artigo
Inglês
| MEDLINE | ID: mdl-25119033
15.
Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants.
N Engl J Med
; 385(7): 664-666, 2021 08 12.
Artigo
Inglês
| MEDLINE | ID: mdl-34233096
16.
Virological Control by the CD4-Binding Site Antibody N6 in Simian-Human Immunodeficiency Virus-Infected Rhesus Monkeys.
J Virol
; 91(16)2017 08 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28539448
17.
Protective Efficacy of Broadly Neutralizing Antibodies with Incomplete Neutralization Activity against Simian-Human Immunodeficiency Virus in Rhesus Monkeys.
J Virol
; 91(20)2017 10 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28768869
18.
Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs.
J Virol
; 90(3): 1321-32, 2016 02 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26581981
19.
Optimization of the Solubility of HIV-1-Neutralizing Antibody 10E8 through Somatic Variation and Structure-Based Design.
J Virol
; 90(13): 5899-5914, 2016 07 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27053554
20.
New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency.
J Virol
; 90(1): 76-91, 2016 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-26468542